Загрузка...
Predict New Therapeutic Drugs for Hepatocellular Carcinoma Based on Gene Mutation and Expression
Hepatocellular carcinoma (HCC) is the fourth most common primary liver tumor and is an important medical problem worldwide. However, the use of current therapies for HCC is no possible to be cured, and despite numerous attempts and clinical trials, there are not so many approved targeted treatments...
Сохранить в:
| Опубликовано в: : | Front Bioeng Biotechnol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6997129/ https://ncbi.nlm.nih.gov/pubmed/32047745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2020.00008 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|